SWEETLEAD: an In Silico Database of Approved Drugs,Regulated Chemicals,and Herbal Isolates for Computer-Aided Drug Discovery

In the face of drastically rising drug discovery costs, strategies promising to reduce development timelines and expenditures are being pursued. Computer-aided virtual screening and repurposing approved drugs are two such strategies that have shown recent success. Herein, we report the creation of a highly-curated in silico database of chemical structures representing approved drugs, chemical isolates from traditional medicinal herbs, and regulated chemicals, termed the SWEETLEAD database. The motivation for SWEETLEAD stems from the observance of conflicting information in publicly available chemical databases and the lack of a highly curated database of chemical structures for the globally approved drugs. A consensus building scheme surveying information from several publicly accessible databases was employed to identify the correct structure for each chemical. Resulting structures are filtered for the active pharmaceutical ingredient, standardized, and differing formulations of the same drug were combined in the final database. The publically available release of SWEETLEAD (https://simtk.org/home/sweetlead) provides an important tool to enable the successful completion of computer-aided repurposing and drug discovery campaigns.     

Radioisotopic assay of femtomole quantities of total adenine nucleotides,ATP plus ADP,and AMP

AMP is converted to ATP by incubating overnight with pyruvate kinase, phosphoenolpyruvate and adenylate kinase in th prensence of endogenous ATP (ADP) as primer. In a subsequent incubation in the presence of pyruvate kinase, phosphoenolpyruvate, radioactive glucose and hexokinase. ATP and ADP are estimated together by coupling their recycling to the formation of glucose 6-phosphate. The latter is separated by precipitation using 76% (v/v) acetone for radioactivity measurement in the same Eppendorf tube. The sensitivity of these simple procedures matches or exceeds those of luciferase methods of nucleotide determination.     

gamma-butyrobetaine in tissues and serum of fed and starved rats determined by an enzymic radioisotopic procedure.

A method for the determination of picomole quantities of gamma-butyrobetaine and its application for the determination of gamma-butyrobetaine distribution in tissues are described. The method is based on the quantitative conversion of gamma-butyrobetaine into carnitine by using a 50-60%-satd.-(NH4)2SO4 fraction of rat liver supernatant as the source of gamma-butyrobetaine hydroxylase [4-trimethylaminobutyrate,2-oxoglutarate:oxygen oxidoreductase (3-hydroxylating), EC 1.14.11.1]; the carnitine formed is then measured enzymically. The mean gamma-butyrobetaine content, as nmol/g wet wt. of tissue, ranged from a low of 4.6 in livers to a high of 12.3 in hearts of normal fed male adult rats. Starvation for 48 h did not affect the gamma-butyrobetaine concentration in serum, liver and brain, but that in skeletal muscles, kidney and heart was increased. These data are in line with the present views that most tissues are able to produce gamma-butyrobetaine, and show that starvation enhances the synthesis and/or the retention of this compound in many tissues. The observed high affinity of gamma-butyrobetaine hydroxylase for gamma-butyrobetaine (Km 7 microM), the high activity of this enzyme and the low concentration of gamma-butyrobetaine in liver indicate that gamma-butyrobetaine availability is one of the factors that normally limit carnitine synthesis.     

Purple membrane: color, crystallinity, and the effect of dimethyl sulfoxide

In an effort to understand the nature of chromophore-protein interactions in bacteriorhodopsin (bR), we have reinvestigated dimethyl sulfoxide (DMSO)-induced changes in bR [Oesterhelt et al. (1973) Eur. J. Biochem. 40, 453-463]. We observe that dark-adapted bR (bR560) in aqueous DMSO undergoes reversible transformation to a species absorbing maximally at 480 nm (bR480). Beginning at 40% DMSO, this change results in complete conversion to bR480 at 60% DMSO. The kinetics of the reaction reveal that this transformation takes place predominantly through the all-trans isomeric form of the pigment. Thermal isomerization of the 13-cis chromophore to the all-trans form is, therefore, the rate-limiting step in the formation of bR480 from the dark-adapted bR. As in native bR, the chromophore in bR480 is linked to the protein via a protonated Schiff base, and its isomeric composition is predominantly all-trans. The formation of bR480 is associated with minor changes in the protein secondary structure, and the membrane retains crystallinity. These changes in the protein structure result in a diminished chromophore-protein interaction near the Schiff base region in bR480. Thus, we attribute the observed spectroscopic changes in bR in DMSO to structural alteration of the protein. The 13-cis chromophoric pigment appears to be resistant to this solvent-induced change. The changes in the protein structure need not be very large; displacement of the protein counterion(s) to the Schiff base, resulting from minor changes in the protein structure, can produce the observed spectral shift.     

NH2-terminal sequences of DNA-, heparin-, and gelatin-binding tryptic fragments from human plasma fibronectin

NH₂-terminal sequence analysis was performed on subregions of human plasma fibronectin including 24,000-dalton (24K) DNA-binding, 29,000-dalton (29K) gelatin-binding, and 18,000-dalton (18K) heparin-binding tryptic fragments. These fragments were obtained from fibronectin after extensive trypsin digestion followed by sequential affinity purification on gelatin-Sepharose, heparin-agarose, and DNA-cellulose columns. The gelatin-binding fragment was further purified by gel filtration on Sephadex G-100, and the DNA-binding and heparin-binding fragments were further purified by high-performance liquid chromatography. The 29K fragment had the following NH₂-terminal sequence: AlaAlaValTyrGlnProGlnProHisProGlnProPro (Pro)TyrGlyHis HisValThrAsp(His)(Thr)ValValTyrGly(Ser) ?(Ser)?-Lys. The NH₂-terminal sequence of a 50K, gelatin-binding, subtilisin fragment by L. I. Gold, A. Garcia-Pardo, B. Prangione, E. C. Franklin, and E. Pearlstein (1979, Proc. Nat. Acad. Sci. USA76, 4803–4807) is identical to positions 3–19 (with the exception of some ambiguity at position 14) of the 29K fragment. These data strongly suggest that the 29K tryptic fragment is included in the 50K subtilisin fragment, and that subtilisin cleaves fibronectin between the Ala²Val³ residues of the 29K tryptic fragment. The 18K heparin-binding fragment had the following NH₂-terminal sequence: (Glu)AlaProGlnProHisCysIleSerLysTyrIle LeuTyrTrpAspProLysAsnSerValGly?(Pro) LysGluAla?(Val)(Pro). The 29K gelatin-binding and 18K heparin-binding fragments have proline-rich NH₂-terminal sequences suggesting that they may have arisen from protease-sensitive, random coil regions of fibronectin corresponding to interdomain regions preceding macromolecular-binding domains. Both of these fragments contain the identical sequence ProGlnProHis, a sequence which may be repeated in other interdomain regions of fibronectin. The 24K DNA-binding fragment has the following NH₂-terminal sequence: SerAspThrValProSerProCysAspLeuGlnPhe ValGluValThrAspVal LysValThrIleMetTrpThrProProGluSerAla ValThrGlyTyrArgVal AspValCysProValAsnLeuProGlyGluHisGly Gln(Cys)LeuProIleSer. The sequence of positions 9–22 are homologous to positions 15–28 of the α chain of DNA-dependent RNA polymerase from Escherichia coli. The homology observed suggests that this stretch of amino acids may be a DNA-binding site.     

Selectivity of oxidase and reductase activity of horse heart cytochrome c

The ascorbate-TMPD-cytochrome $\text{c}$ oxidase and succinate cytochrome $\text{c}$ reductase activities and the redox potentials of native and chemically modified cytochromes $\text{c}\text{—NBS-cytochrome}\text{c}$ with modification of Trp-59 and Met-65, nitro-cytochrome $\text{c}$ with modification of Tyr-67, and a new preparation, Chloramine-T-cytochrome m$\text{c}$ with modification of Met-80 and -65 to methionine sulfoxide—have been compared at pH 7.8 in 25 mM cacodylate-Tris buffer. These modifications exhibit (i) a slight lowering of redox potential, from 260 mV to 180, 215 and 170 mV, respectively, (ii) destabilization of the cytochrome $\text{c}$-reductase complex, 6 to 12 fold, but without alteration of the cytochrome $\text{c}$-oxidase complex, and (iii) a slight lowering of the maximum velocity for both the oxidase and reductase reactions. The selective destabilization of the cytochrome $\text{c}$-reductase complex is interpreted as an indication of a two-path, two-function model for the oxido-reduction function of cytochrome $\text{c}$.     

Three-species ecosystems in a solvable model

A detailed discussion of the three-species ecosystems is presented in an exactly solvable model with interactions of the Gompertz form. Three different possibilities, namely, a one-prey-two-predator system, a two-prey-one-predator system and a three-step prey-predator food chain are considered. These systems are studied not only when they include their basic prey-predator interactions, but also when various self-interactions as well as competition between like species, in different possible combinations, are included. It is then inferred, by obtaining and examining the exact solutions, as to when these systems possess stable equilibrium and when not, or when they are purely oscillatory, etc. We also study, within our model, the two-species versus three-species situation. It is seen that there are situations when the three-species system possesses stable equilibrium even under circumstances under which the corresponding two-species system is unstable. We also come across cases when the addition of the third species destroys the possibility of stable equilibrium which the initial two-species system possessed. Some other results also follow. Of particular interest is the one where the initial two-species system is purely oscillatory but the enlarged system, which is a three-step prey-predator chain, has the first and the last populations of the chain rising indefinitely and the middle population remains oscillatory. A comparison of our results with results of other authors, wherever possible, has also been made.     

Intermolecular protein interactions in solutions of calf lens alpha-crystallin. Results from 1/T1 nuclear magnetic relaxation dispersion profiles.

From analyses of the magnetic field dependence of 1/T1 (NMRD profiles) of water protons in solutions of calf lens alpha-crystallin at several concentrations, we find two regimes of solute behavior in both cortical and nuclear preparations. Below approximately 15% vol/vol protein concentration, the solute molecules appear as compact globular proteins of approximately 1,350 (cortical) and approximately 1,700 (nuclear) kD. At higher concentrations, the effective solute particle size increases, reversibly, as evidenced by the appearance of spectra-like 14N peaks in the NMRD profiles and a change in the field and temperature dependence of 1/T1. At these higher concentrations, the profiles are very similar to those of calf gamma II-crystallin, a crystallin that undergoes an analogous transition near approximately 15% protein (Koenig, S. H., C.F. Beaulieu, R. D. Brown III, and M. Spiller, 1990. Biophys. J. 57:461-469). By comparison with recent analyses of NMRD results for solutions of immobilized proteins as models for the transition from protein solutions to tissue (Koenig, S. H., and R. D. Brown III. 1991. Prog. NMR Spectr. 22:487-567), we argue that alpha-crystallin solute behaves as aggregates approximately greater than 50,000 kD as protein concentration is progressively increased above 15%. Finally, the concentration dependence of the NMRD profiles of alpha- and gamma II-crystallin can readily explain recent osmotic pressure data, in particular the intersection of the respective pressure curves at approximately 23% vol/vol (Vérétout, F., and A. Tardieu. 1989. Eur. Biophys. J. 17:61-68).